In order to study the antigenicity of envelope 46 kDa glycoprotein (gp46) of human T-cell leukemia virus type-I (HTLV-I), we have generated monoclonal anti-gp46 antibodies (MAbs), REY-7, REY-I I, REY-16, REY-30, MET4 and MET-3 from rats and mice. lmmunoblot and immunofluorexence assays showed that t
Generation, characterization and cross-reactivities of monoclonal antibodies against the p24 core protein and the gp130 envelope glycoprotein of HIV-2ben
✍ Scribed by Arne-C. Faißt; Ahlert Otteken; Sigrid Nick; Gerhard Hunsmann
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 551 KB
- Volume
- 182
- Category
- Article
- ISSN
- 0300-8584
No coin nor oath required. For personal study only.
✦ Synopsis
The purpose of this study was to characterize antigenic determinants on structural polypeptides of human immunodeficiency virus type 2 (HIV-2ben). Therefore, three HIV-2-specific monoclonal antibodies (mAbs) against the p24 core protein (gag) and one mAb against the gpl30 envelope glycoprotein (env) were produced. In addition to p24 the anti-core mAbs recognized the primary translation product of the viral gag gene p55 and an intermediate cleavage product p41. Core mAbs cross-reacted with another HIV-2 isolate (HIV-2rod), and several simian immunodeficiency viruses (SIVagmTYO7 and SIVmac) , but not with SIVmn d and the HIV-1 isolates investigated (HIV-lhan and HIV-11ai). The env mAb crossreacted with HIV-2rod and SIVma c but not with SIWagm, SIVmn d or HIV-1. In competition assays and with epitope mapping possible binding sites for the mAbs were identified. The processing of HIV-2 core proteins is compared in retrovirusinfected T cell lines and during the expression by recombinant vaccinia virus. Finally, the mAb XIV DC10 which recognized a highly conserved epitope could be useful for an assay to detect HIV-1 and HIV-2 simultaneously. II D8 is the first mAb raised against HIV-2 env glycoprotein.
📜 SIMILAR VOLUMES